Zhengye Biotechnology Holding (ZYBT) Cash & Current Investments (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Zhengye Biotechnology Holding (ZYBT) has disclosed Cash & Current Investments for 2 consecutive years, with $2.8 million as the latest value for Q4 2024.

• Quarterly Cash & Current Investments rose 23.24% to $2.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2024, up 23.24% year-over-year, with the annual reading at $2.8 million for FY2024, 20.92% up from the prior year.
• Cash & Current Investments for Q4 2024 was $2.8 million at Zhengye Biotechnology Holding, up from $2.3 million in the prior quarter.
• The five-year high for Cash & Current Investments was $2.8 million in Q4 2024, with the low at $2.3 million in Q4 2023.

Peer Comparison